Histogen's method of generating multipotent stem cells receives US patent

Histogen, Inc., a regenerative medicine company developing innovative therapies for conditions including hair loss and cancer, has announced that the United States Patent & Trademark Office has issued patent 8,524,494, entitled "Low Oxygen Tension and bFGF Generates a Multipotent Stem Cell from a Fibroblast In Vitro" to the Company.

http://www.medilexicon.com/medicalnews.php?newsid=265684